Besides, expression of two key protein factors controlling de novo lipogenesis, SREBP-1 and FASN, was highly elevated in clinical prostate cancer and CRPC specimens compared to normal/non-tumor prostate tissues [11,16,19,20]. This evidence concerns the gene SREBF1 and neoplasm.